-->

Tag: Seagen Inc

Home / Seagen Inc

Categories

Accelerated approval is granted by FDA to tucatinib with trastuzumab for colorectal cancer

In February 2023, the Food and Drug Administration (FDA) sped up the approval of tucatinib (Tukysa, Seagen Inc.) and trastuzumab for the treatment of RAS wild-type HER2-positive colorectal cancer tha...
seagen-inc

Brentuximab vedotin is approved by FDA in combination with chemotherapy for pediatric patients with classical Hodgkin lymphoma

November 2022: The combination of doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide with brentuximab vedotin (Adcetris, Seagen, Inc.) has been approved by the Food and Drug Adminis...
seagen-inc

We Are Online! Chat With Us!
Scan the code